Profound Medical Corp. Reports Third Quarter 2026 Financial Results and Leadership Changes

Profound Medical reported third-quarter 2026 revenue growth of 86% year over year and a gross margin of 78%. It expects full-year 2026 revenue of at least $25.0 million and a gross margin of at least 70%. The company partnered with Cook Medical to include its TULSA-PRO system in Cook’s iMRI Suite offering through the Copernicus program. Richard Fabian will become CEO on January 14, 2027, while current CEO Arun Menawat becomes Executive Chairman; Matthew Sobczyk was named permanent CFO and Jason Mills joined the board.